A 13-year Nationwide Analysis of Outcomes of Non-variceal Upper Gastrointestinal Bleeding in Post-bariatric Surgery Patients

Overview

Journal Transl Gastroenterol Hepatol

Publisher AME Publishing Company

Specialty Gastroenterology

Date 2025 Feb 13

PMID 39944580

Authors

James R Pellegrini Jr

Andrej M Sodoma

Samuel Greenberg

Sonika Rathi

Nicholas Knott

Richard Pellegrini

Jaspreet Singh

Affiliations

Soon will be listed here.

Abstract

Background: Non-variceal upper gastrointestinal bleeding (NVUGIB) is a common cause of hospitalization and associated morbidity and mortality. Bariatric surgery is a widely performed category of gastrointestinal (GI) surgery that attempts to induce weight loss by reconstructing the upper GI tract. Bleeding is a common complication of bariatric surgery; however, limited research exists on outcomes for these patients when admitted for NVUGIB compared to those without a history of bariatric surgery. Our study aims to evaluate the outcomes of post-bariatric surgery patients (PBSPs) admitted with NVUGIB over a 13-year span.

Methods: The National Inpatient Sample (NIS) from 2008 to 2020 was used to identify patients over 18 years old admitted for NVUGIB using the International Classification of Disease (ICD), 9 revision (ICD-9) and 10 revision (ICD-10) codes. Records were weighted using the algorithms provided by the NIS. Primary outcomes of interest were all-cause hospital mortality, shock, acute myocardial infarction (AMI), acute kidney injury (AKI), and a composite of these. Groups were defined based on the history of bariatric surgery, and demographics and incidence of comorbidities were compared. Outcomes were compared between the two groups, and odds ratios (ORs) were calculated using two-stage weighted logistic regression. ORs were adjusted for common co-founders such as age, gender, race, Charlson comorbidity index (CCI), region, hospital size, hospital teaching status, elective emergency admission, and income quartile.

Results: A total of 2,231,826 patients admitted for NVUGIB were included in this study. Of these, 28,167 had a history of bariatric surgery. Overall, bariatric surgery patients were younger, less complicated (CCI: 2.71 4.76), had a shorter length of stay (LOS), and were less likely to be on Medicare/Medicaid than those without a history of bariatric surgery (P<0.05). Several comorbidities were more common in patients without a history of bariatric surgery, including coronary artery disease, hyperlipidemia (HLD), congestive heart failure (CHF), type 2 diabetes mellitus (T2DM), end-stage renal disease (ESRD), and liver cirrhosis (P<0.05). Other comorbidities were more common in the post-bariatric surgery group, including gastroesophageal reflux disease and anemia (P<0.05). We found that patients admitted for NVUGIB with a history of bariatric surgery had significantly lower odds of all outcomes, including all-cause mortality (OR =0.48; P<0.001), AKI (OR =0.71; P<0.001), AMI (OR =0.62; P<0.05), shock (OR =0.88; P<0.05), and a composite of these four (OR =0.77; P<0.001).

Conclusions: Our study found that patients with NVUGIB and a history of bariatric surgery had substantially decreased odds of mortality, AMI, shock, and AKI compared to patients without a history of bariatric surgery. This suggests that patients with a history of bariatric surgery experienced more minor bleeds than other patients. Further studies are therefore warranted to understand the postoperative risk of bariatric surgery.

References

Campos G, Khoraki J, Browning M, Pessoa B, Mazzini G, Wolfe L . Changes in Utilization of Bariatric Surgery in the United States From 1993 to 2016. Ann Surg. 2019; 271(2):201-209. DOI: 10.1097/SLA.0000000000003554. View

Lanas A, Carrera-Lasfuentes P, Arguedas Y, Garcia S, Bujanda L, Calvet X . Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol. 2014; 13(5):906-12.e2. DOI: 10.1016/j.cgh.2014.11.007. View

Wolfe B, Kvach E, Eckel R . Treatment of Obesity: Weight Loss and Bariatric Surgery. Circ Res. 2016; 118(11):1844-55. PMC: 4888907. DOI: 10.1161/CIRCRESAHA.116.307591. View

De Backer D, Creteur J, Dubois M, Sakr Y, Vincent J . Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J. 2003; 147(1):91-9. DOI: 10.1016/j.ahj.2003.07.006. View

Abougergi M, Peluso H, Mrad C, Saltzman J . The Impact of Obesity on Mortality and Other Outcomes in Patients With Nonvariceal Upper Gastrointestinal Hemorrhage in the United States. J Clin Gastroenterol. 2017; 53(2):114-119. DOI: 10.1097/MCG.0000000000000942. View

Bardou M, Benhaberou-Brun D, Le Ray I, Barkun A . Diagnosis and management of nonvariceal upper gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol. 2012; 9(2):97-104. DOI: 10.1038/nrgastro.2011.260. View

Navaneethan S, Yehnert H . Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009; 5(6):662-5. DOI: 10.1016/j.soard.2009.01.006. View

Batsis J, Romero-Corral A, Collazo-Clavell M, Sarr M, Somers V, Brekke L . Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring). 2007; 15(3):772-84. DOI: 10.1038/oby.2007.589. View

Bjornstad P, Nehus E, van Raalte D . Bariatric surgery and kidney disease outcomes in severely obese youth. Semin Pediatr Surg. 2020; 29(1):150883. PMC: 7125208. DOI: 10.1016/j.sempedsurg.2020.150883. View

10.

. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009; 5(3):387-405. DOI: 10.1016/j.soard.2009.01.010. View

11.

Chang P, Friedenberg F . Obesity and GERD. Gastroenterol Clin North Am. 2014; 43(1):161-73. PMC: 3920303. DOI: 10.1016/j.gtc.2013.11.009. View

12.

Lupoli R, Lembo E, Saldalamacchia G, Avola C, Angrisani L, Capaldo B . Bariatric surgery and long-term nutritional issues. World J Diabetes. 2017; 8(11):464-474. PMC: 5700383. DOI: 10.4239/wjd.v8.i11.464. View

13.

Berger S, Meyre P, Blum S, Aeschbacher S, Ruegg M, Briel M . Bariatric surgery among patients with heart failure: a systematic review and meta-analysis. Open Heart. 2019; 5(2):e000910. PMC: 6307626. DOI: 10.1136/openhrt-2018-000910. View

14.

Adam V, Barkun A, Viviane A, Alan B . Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States. Value Health. 2008; 11(1):1-3. DOI: 10.1111/j.1524-4733.2007.00208.x. View

15.

Niu C, Zhang J, Ukrani H, Han Y, Weerasinghe D, Balmer-Swain M . Reduction of cardiovascular complications during delivery hospitalization in patients undergoing bariatric procedures. Int J Obes (Lond). 2024; 48(8):1133-1139. DOI: 10.1038/s41366-024-01532-4. View

16.

Kwok C, Pradhan A, Khan M, Anderson S, Keavney B, Myint P . Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014; 173(1):20-8. DOI: 10.1016/j.ijcard.2014.02.026. View

17.

Nojkov B, Cappell M . Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis. World J Gastroenterol. 2016; 22(1):446-66. PMC: 4698507. DOI: 10.3748/wjg.v22.i1.446. View

18.

Camilleri M, Malhi H, Acosta A . Gastrointestinal Complications of Obesity. Gastroenterology. 2017; 152(7):1656-1670. PMC: 5609829. DOI: 10.1053/j.gastro.2016.12.052. View

19.

Alexandrou A, Armeni E, Kouskouni E, Tsoka E, Diamantis T, Lambrinoudaki I . Cross-sectional long-term micronutrient deficiencies after sleeve gastrectomy versus Roux-en-Y gastric bypass: a pilot study. Surg Obes Relat Dis. 2013; 10(2):262-8. DOI: 10.1016/j.soard.2013.07.014. View

20.

Shariq O, McKenzie T . Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020; 9(1):80-93. PMC: 7082272. DOI: 10.21037/gs.2019.12.03. View